Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by mmayeron Jun 26, 2018 1:42pm

48 Views

Post# 28231264

L2

Cote de niveau 2

Cotes de niveau 2 – Cours acheteur
Nombre d'actions		Cours acheteur
180 000 actions	180 000	0,145
220 000 actions	220 000	0,140
425 000 actions	425 000	0,135
130 000 actions	130 000	0,130
166 500 actions	166 500	0,125
271 000 actions	271 000	0,120
247 000 actions	247 000	0,115
384 000 actions	384 000	0,110
361 000 actions	361 000	0,105
315 000 actions	315 000	0,100

Cotes de niveau 2 – Cours vendeur
Cours vendeur	Nombre d'actions
0,150	85 000	85 000 actions
0,155	81 500	81 500 actions
0,160	174 000	174 000 actions
0,165	272 000	272 000 actions
0,170	320 000	320 000 actions
0,175	38 500	38 500 actions
0,180	134 000	134 000 actions
0,185	45 000	45 000 actions
0,190	178 500	178 500 actions
0,195	83 000